Autres langues Nectar Lifesciences Limited

Actions

NECLIFE

INE023H01027

Produits pharmaceutiques

Marché Fermé - NSE India S.E. Autres places de cotation 13:05:08 30/06/2026			Varia. 5j.	Varia. 1 janv.
11,57 ^INR	-0,86%		-2,12%	-40,39%

30/05	Nectar Lifesciences Limited publie ses résultats pour le quatrième trimestre et l'exercice clos le 31 mars 2026	CI
06/03	Nectar Lifesciences Limited (NSEI:NECLIFE) a finalisé l'acquisition d'Avensis Exports Private Limited.	CI

Autres langues

30/05	Nectar Lifesciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
06/03	Nectar Lifesciences Limited completed the acquisition of Avensis Exports Private Limited.
02/03	Nectar Lifesciences to acquire 100% paid-up equity share capital of Avensis Exports
02/03	Nectar Lifesciences Limited agreed to acquire Avensis Exports Private Limited for INR 2.5 million.
23/01	Nectar Lifesciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
15/01	Tranche Update on Nectar Lifesciences Limited's Equity Buyback Plan announced on December 3, 2025.
06/01	Nectar Lifesciences Limited's Equity Buyback announced on May 6, 2023, has closed with 30,000,000 shares, representing 13.38% for INR 810 million.
20/12	Capnest Health Care Private Limited entered into Business Transfer agreement to acquire Empty Hard Gelatin Capsule unit at Bhatoli from Nectar Lifesciences Limited for approximately INR 200 million.
03/12	Nectar Lifesciences approves buyback of shares valued at 810 million rupees
03/12	Nectar Lifesciences Limited Appoints Sushil Kapoor as Additional Director and Whole-Time Director, Effective December 4, 2025
03/12	Nectar Lifesciences Limited announces an Equity Buyback for 30,000,000 shares, representing 13.38% for INR 810 million.
03/12	Nectar Lifesciences Limited authorizes a Buyback Plan.
27/11	Nectar Lifesciences proposes buyback of equity shares
27/11	Nectar Lifesciences Limited 's Board intends to launch an Equity Buyback on December 3, 2025.
14/11	Nectar Lifesciences Limited Announces Changes in Registered and Corporate Offices
12/11	Nectar Lifesciences Completes Slump Sale of API and Formulations Business; Shares Slip 3%
11/11	Nectar Lifesciences Limited Announces Executive and Directorate Changes, Effective November 10, 2025
11/11	Nectar Lifesciences Limited Announces Cessation of Amit Chadah as Chief Executive Officer, Effective November 10, 2025
10/11	Ceph Lifesciences Private Limited completed the acquisition of manufacture, distribution, marketing and sale business of Nectar Lifesciences Limited for INR 12.54 billion.
10/11	Ceph Lifesciences Private Limited completed the acquisition of menthol business of Nectar Lifesciences Limited.
27/10/25	Nectar Lifesciences Limited Announces Cessation of Meena Verma as Member of the Board of Directors, with Effect from October 27, 2025
22/10/25	Nectar Lifesciences says secured debt and interest owed by co fully repaid and settled with banks
16/09/25	Nectar Lifesciences says Directorate of Revenue Intelligence conducted search at co
14/08/25	Nectar Lifesciences posts June-quarter consol loss of 632.3 million rupees
14/08/25	Nectar Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025